Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 6, 2023ACS Infectious DiseasesOpen Access

Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

LJLaura N. JeffreysLiverpool School of Tropical MedicineAAAlison ArdreyLiverpool School of Tropical MedicineTHTaghreed A. HafizKing Saud University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jeffreys et al. (2023) studied this question.

synapsesocial.com/papers/6a92528a0e9b60bc4641ea4dhttps://doi.org/10.1021/acsinfecdis.2c00283
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of MGIT 960-Based Antimicrobial Testing and Determination of Critical Concentrations of First- and Second-Line Antimicrobial Drugs with Drug-Resistant Clinical Strains of Mycobacterium tuberculosis2006 · 129 citations
  2. 2The purification and characterization of the cytochrome d terminal oxidase complex of the Escherichia coli aerobic respiratory chain.1983 · 207 citations
  3. 3Semisynthesis and Antiplasmodial Activity of the Quinoline Alkaloid Aurachin E2008 · 35 citations
  4. 4Structure of a bd oxidase indicates similar mechanisms for membrane-integrated oxygen reductases2016 · 172 citations
  5. 5Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism2014 · 306 citations